Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Manufacturing & Bioprocessing
Cell and Gene Manufacturing Approaches and Winning Strategies for Commercialisation and Scale-Up
With a host of factors to consider in cell and gene manufacture, upscaling is still no small task. However, as industry experience accumulates and new technologies arrive on the market, there are an increasing number of options for developers looking to get their therapeutic on the road to the clinic.
Immuno-Oncology
Evaxion Biotech Announce New Source of Immunotherapeutic Targets via AI Platform
ERVs have been strongly associated with overall survival in cancer patients. Evaxion hopes they can act as therapeutic targets for non-responsive immunotherapy patients.
Immunotherapy (Non-Oncology)
Novel Targets and Studies in Immunology and Autoimmunity: Antigen-Specific Immunotherapy and Therapeutic Chaperones
Insights on antigen-specific immunotherapy and the immunomodulatory functions of therapeutic chaperones at Immuno UK 2022.
NextGen Therapeutics
FDA's AI Model Enhances Safety of Biosimilar Therapeutic Proteins
Thanks to the FDA's new AI-powered imaging tool, the safety profile of newly developed biosimilar therapeutic protiens may improve.
Antibody & Protein Engineering
Interview with Andrew Brown, Head of Process Development Sciences at Lonza
Andrew Brown, Head of Process Development Sciences at Lonza, talks about Lonza's approach to process development.
Peptide Chemistry
AI-Discovered Peptide has Dramatic Impact on Muscle Conditioning
Are plant-derived peptides set to replace animal proteins as the go-to supplement for muscle conditioning?
Oligo Chemistry
The Complex Case of Antisense Oligonucleotides
We gain a glimpse into what the landscape of antisense oligonucleotides looks like today, from computational representations to protein purification.